RxDoctor Payments Data

Rizelle Talon

Primary Care · Waipahu, HINPI 1174371520

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 181 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AstraZeneca at 31.7% of the total.

$5,017in general payments, 2019–2025

Across 181 payments — averaging $27.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • AbbVie$698
  • Kowa Pharmaceuticals America, Inc.$438
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$313
  • Amgen$312
  • Gilead$285
  • plus $1K from 13 others

What the payments were for

  • Food & beverage$5,017100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,017 in reported general payments places this provider in the 75th percentile of 24 primary care providers in Hawaii.

See all primary care providers in Hawaii

Other primary care in Waipahu

See the full list for Hawaii

Where these figures come from

Is this you, or does something look wrong? →